BCDA BioCardia, Inc.

BEARISH Impact: 8/10 8-K
Horizon weeks Filed Apr 15, 2026 Processed 1mo ago SEC 0001437749-26-012412
8-K context-dependent: Items 3.01
Latest settled — T+20d
BCDA ▼ -10.08% at T+20d
SHORT call ✓ call won +10.08% · α vs SPY +15.90% · entry $1.19 → $1.07
Next anchor: T+60d in 27d
Currently $0.8800 · +26.05% from $1.19 entry (call sign-flipped)
Entry anchored
Apr 14, 03:54 PM ET
via Databento tick
T+1d
-0.84%
call +0.84% · α +2.06%
$1.18
settled 8w ago
T+5d
-1.68%
call +1.68% · α +2.66%
$1.17
settled 7w ago
T+20d
-10.08%
call +10.08% · α +15.90%
$1.07
settled 4w ago
T+60d
call — · α —
in 27d

Price Chart

Loading chart...

Executive Summary

BioCardia received a Nasdaq delisting notice due to failing the $2.5 million minimum stockholders' equity requirement, with stockholders' equity at $895,000 as of December 31, 2025. The company has until May 25, 2026 to submit a compliance plan and may receive up to 180 days to regain compliance.

Actionable Insight

Monitor whether BioCardia can secure additional capital or execute a reverse stock split to regain compliance by October 7, 2026 (180 days from notice). Failure to submit an acceptable plan by May 25 could trigger immediate delisting proceedings.

Key Facts

  • Received Nasdaq delisting notice for failing minimum stockholders' equity requirement of $2.5 million
  • Stockholders' equity was $895,000 as of December 31, 2025
  • Company has until May 25, 2026 to submit a compliance plan
  • Nasdaq may grant up to 180 calendar days from April 10, 2026 to regain compliance
  • Stock continues to trade on Nasdaq under symbol BCDA while the process unfolds

Financial Impact

Company's stockholders' equity of $895,000 is 64.2% below the $2.5 million Nasdaq minimum requirement

market valueliquidityinvestor confidence

Risk Factors

  • Delisting from Nasdaq which would reduce institutional ownership and liquidity
  • Potential inability to raise capital needed to meet equity requirements

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-012412
Document: 0001437749-26-012412-index-headers.html0001437749-26-012412
Document: 0001437749-26-012412-index.html0001437749-26-012412
Document: 0001437749-26-012412.txt0001437749-26-012412
16 reports for BCDA
Performance horizon
29% Hit rate 2 of 7 directional calls best @ T+5▲ +3.33%Mar 24, 2026
Filters
Rows
Reports for BCDA — sortable, filterable
Type Now
Jun 12, 2026
1d ago
8-K
NEUTRAL ★ 5/10
$0.8165 awaiting T+5awaiting T+5$0.8800 (+7.78%)
Jun 8, 2026
5d ago
8-K
BEARISH ★ 6/10
$0.8800 awaiting T+5awaiting T+5$0.8800 (+0.00%)
Jun 8, 2026
5d ago
Press Release
BEARISH ★ 7/10
$0.8800 awaiting T+5awaiting T+5$0.8800 (+0.00%)
Jun 5, 2026
8d ago
8-K
BULLISH ★ 6/10
$1.20 awaiting T+5awaiting T+5$0.8800 (−26.67%)
May 28, 2026
16d ago
8-K
BULLISH ★ 7/10
$0.9200 $0.8700▼ −5.43%▼ −5.39%$0.8800 (−4.35%)
May 15, 2026
29d ago
8-K
MIXED ★ 6/10
$1.01 $0.9600▼ −4.95%▼ −5.91%$0.8800 (−12.87%)
May 15, 2026
29d ago
Press Release
MIXED ★ 6/10
$1.01 $0.9600▼ −4.95%▼ −5.91%$0.8800 (−12.87%)
May 11, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$1.12 $0.9000▼ −19.64%▼ −19.72%$0.8800 (−21.43%)
May 8, 2026
5w ago
8-K
BULLISH ★ 6/10
$1.11 $1.09▼ −1.80%▼ −3.27%$0.8800 (−20.72%)
Apr 28, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$1.14 $1.13▼ −0.88%▼ −2.57%$0.8800 (−22.81%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (48h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access